Identification of a novel peptide ligand for the cancer-specific receptor mutation egfrviii using high-throughput sequencing of phage-selected peptides

HIGHLIGHTS

• who: Sourour Mansour from the Center for Protein have published the research work: Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides, in the Journal: Scientific Reports Scientific Reports of 28/Nov/2022
• what: The de novo conformation of the VLGREEWSTSYW peptide used in the current experiment shows varying possibilities to achieve a secondary_structure. The model lowest binding affinity value was considered as best conformation for further analysis and interaction data with the target protein.
• how: The eluates from the three . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.